3B Pharmaceuticals GmbH

Magnusstraße 11, 12489 Berlin

View address on Google Maps

+49 30 6392-4317

+49 30 6392-4316

info(at)3b-pharma.com

www.3b-pharma.com

Contact

Dr. Jan Michel

Focus

3B Pharmaceuticals GmbH is a privately held pharmaceutical R&D company based in Berlin, Germany. The company is dedicated to the development of peptide-based pharmaceutical and diagnostic products. 3B Pharmaceuticals is pursuing R&D projects in hemophilia and oncology (nuclear medicine).

Categories

In synch with success

Two companies who broke out in Adlershof now move into their own headquarters

3B Pharmaceuticals enters into a Global Exclusive Licensing Agreement for its FAP-Targeting Peptide Technology

Licensing agreement with Novartis includes exclusive worldwide rights to develop and commercialize therapeutic and imaging applications for 3BP's ...

Growing importance of nuclear medicine for the treatment of cancer

Debiopharm expands its radiopharmaceutical footprint with an exclusive in-licensing agreement of 3B Pharmaceutical’s targeted CAIX radiotherapy

New partners in cancer research

Clovis Oncology acquires rights to FAP-targeted radiopharmaceutical program from 3B Pharmaceuticals and to discovery program for three additional ...

Boehringer Ingelheim and 3B Pharmaceuticals sign drug discovery collaboration

Harnessing the structural plethora of peptides to discover novel therapeutics

Ipsen and 3BP announce First Patient Dosed in Phase I/II study for first-in-class radionuclide

The world belongs to those that wait

On the perseverance of entrepreneurs and scientists from Adlershof